Suchergebnisse - "Chiara Cattaneo"

PubPharm (32)

1

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022Research in context

in: EClinicalMedicine | 2024

von Jon Salmanton-García | Francesco Marchesi | Francesca Farina | +265

2

Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda

in: Cancers | 2024

von Giuseppe Rossi | Erika Borlenghi | Patrizia Zappasodi | +17

3

Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study

in: Clinical and Translational Science | 2023

von Pierantonio Menna | Francesco Marchesi | Chiara Cattaneo | +16

4

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience

in: Cancers | 2023

von Luana Fianchi | Fabio Guolo | Francesco Marchesi | +33

5

P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP

in: HemaSphere | 2023

von Francesco Marchesi | Pierantonio Menna | Chiara Cattaneo | +14

6

S292: NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY

in: HemaSphere | 2023

von Jon Salmanton-García | Francesco Marchesi | Maria Gomes Da Silva | +70

7

P778: A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS ITALIAN EXPERIENCE

in: HemaSphere | 2023

von Carmelo Gurnari | Maria Rosaria Pascale | Antonio Vitale | +37

8

P1538: MULTIDRUG RESISTANT BACTERIAL COLONIZATION AND RELATED BLOODSTREAM INFECTIONS IN FEBRILE HAEMATOLOGIC PATIENTS: EPIDEMIOLOGY AND OUTCOME

in: HemaSphere | 2023

von Chiara Cattaneo | Lorenzo Masina | Chiara Pagani | +11

9

Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?

in: Blood Cancer Journal | 2023

von Carlotta Giupponi | Diego Bertoli | Erika Borlenghi | +11

10

Attitude and concerns of healthy individuals regarding post-mortem brain donation. A qualitative study on a nation-wide sample in Italy

in: BMC Medical Ethics | 2023

von Chiara Cattaneo | Iuliia Urakcheeva | Gianmarco Giacomini | +5